Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,408 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06841471Recruiting
Role of Corneal Nerves in Dry Eye Disease
This study looks at how the nerves in the front of the eye (corneal nerves) relate to dry eye disease. It compares people with dry eye to those without to understand differences.
OltenAges 18 years+ - NCT07318805RecruitingPhase 1
A study of PF-08032562 for advanced solid tumors
This study tests a new medicine, PF-08032562, for people with advanced breast or colorectal cancer that has not responded to prior treatments. It aims to see if the drug is safe and can help shrink or slow the cancer.
Duarte, CaliforniaAges 18 years+ - NCT07321925Recruiting
Using sound waves to measure liver fat
This study tests a new method that uses sound waves to measure fat in your liver. It could help doctors check liver health without a biopsy.
Ann Arbor, MichiganAges 18 years+ - NCT06870136Recruiting
Lion's Mane supplement for memory and focus
This study tests a Lion's Mane supplement to see if it helps with memory, focus, and overall thinking. If you are between 40 and 75 and have mild concerns about your thinking, you may be able to take part.
Los Angeles, CaliforniaAges 40–75 - NCT06869603Recruiting
Mediterranean diet for recurrent kidney stones and bone health
This trial looks at whether following the Mediterranean diet helps people who get kidney stones over and over again. It also checks how diet affects bone health. If you have had multiple kidney stones, you may be able to join.
NaplesAges 18 years+ - NCT06868875Recruiting
Small bowel MRI data sharing study
This study asks permission to use past MRI scans of your small bowel for research. It aims to improve how we understand and diagnose bowel conditions.
LondonAges 16 years+ - NCT07323121Recruiting
Flickering light therapy for sleep problems in Parkinson's
This study tests whether a special flickering light (40 Hz) can help improve sleep in people with Parkinson's disease. Participants will be exposed to the light at home, and researchers will track changes in sleep quality.
Nanjing, JiangsuAges 50–75 - NCT07322939Recruiting
Exercise with visual feedback for Parkinson's
This trial tests whether adding visual feedback to exercise can help people with mild to moderate Parkinson's disease improve their movement and balance. It is designed for people who are only taking oral Parkinson's medications.
Gaziantep, ŞahinbeyAges 18–85 - NCT07321769Recruiting
3D eye modeling study for lens and eye structure disorders
This trial uses advanced imaging to create 3D models of the eye in people with lens problems, eye structure anomalies, trauma, or cataract complications. It aims to improve diagnosis and treatment planning for these conditions.
Hangzhou, ZhejiangAges Any age - NCT07321704Recruiting
Irrisept vs. Saline for Pilonidal Flap Surgery
This study compares two types of wound cleaning solutions used during surgery for pilonidal disease: an antiseptic called Irrisept (0.05% chlorhexidine gluconate) versus normal saline. The goal is to see if Irrisept helps prevent infection and improve healing after a flap-based closure procedure.
Los Angeles, CaliforniaAges 18 years+ - NCT07324720Recruiting
Comparing ischemia vs plaque risk for high-risk artery disease
This trial compares two ways to decide which heart artery blockages need treatment: one looks at blood flow, the other at plaque buildup and risk. It's for people with high-risk blockages to see which approach leads to better outcomes.
Seoul, Main BuildingAges 19 years+ - NCT07324161Recruiting
Magnetic Brain Stimulation for Alzheimer's Disease
This trial tests whether a non-invasive magnetic brain stimulation treatment (TMS) can help people with mild to moderate Alzheimer's disease. You would receive the treatment and be monitored for safety and benefit.
Fuzhou, FujianAges 50–90 - NCT07316452Recruiting
Early heart disease risk study for adults under 45
This study looks at what makes heart disease progress in younger adults (18 to 45). If you have symptoms of heart disease and have had a heart CT scan, joining this research might help doctors better predict and manage your condition.
BeijingAges 18–45 - NCT07316504Recruiting
Best method to fix a stent that is not fully open
This trial compares different ways to fix a stent that hasn't expanded properly inside a coronary artery. If you have a narrowed stent (restenosis) that looks like it's not fully open, this study may help determine the best treatment approach.
Clermont-Ferrand, AuvergneAges 18 years+ - NCT07317297Recruiting
Shockwave therapy for Peyronie's disease
This trial tests whether sound waves (extracorporeal shockwave therapy) can help men with stable Peyronie's disease reduce curvature and plaque. It's for those whose condition hasn't changed for at least 6 months and who haven't had other treatments.
BakuAges 18–65 - NCT07323927RecruitingEarly Phase 1
Testing galcanezumab for Alzheimer's disease
This trial tests whether galcanezumab, an antibody injection, can help people with mild-to-moderate Alzheimer's disease. It is for patients who have a confirmed Alzheimer's diagnosis and a caregiver who can support them.
BeijingAges 50–90 - NCT07316621Recruiting
Crohn's disease risk study for close relatives
This study follows close family members of people with Crohn's disease to see if they develop early signs of the condition. It uses blood tests and checkups to detect Crohn's earlier.
RomaAges 16–35 - NCT06873165Recruiting
Gut bacteria treatment for fatty liver disease
This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.
TaipeiAges 18–70 - NCT06873321RecruitingPhase 4
Blood thinners after leg artery surgery to prevent clots
This trial compares two blood-thinning strategies after leg artery surgery or angioplasty to prevent dangerous blood clots. Participants will receive either rivaroxaban plus aspirin or aspirin alone, and researchers will monitor for clots over 30 days.
Pernambuco, PernambucoAges Any age - NCT06871514Recruiting
Decision support for managing heart disease risk
This trial tests a decision-support tool to help manage cardiovascular risk in people with established heart or blood vessel disease. It aims to improve treatment plans and outcomes.
AlkmaarAges 40–80 - NCT04807868Recruiting
Liver fat registry for adults with or at risk for fatty liver
This study builds a research registry (and optional test results follow-up) for adults who either need a routine liver biopsy or may have fatty liver risk based on body weight and other health history. It helps researchers learn more about non-alcoholic fatty liver disease (fatty liver not caused by alcohol) and how it may progress.
Orlando, FloridaAges 18 years+ - NCT07314346RecruitingPhase 1
Study of a new hepatitis C drug with addiction medications
This study checks how a new hepatitis C medicine (bemnifosbuvir/ruzasvir) interacts with medications used for opioid addiction, such as buprenorphine/naloxone or methadone. It helps doctors understand if the new medicine is safe and effective for people taking these addiction treatments.
Hollywood, FloridaAges 18–65 - NCT07308548RecruitingPhase 2
Testing HP515 for fatty liver disease (NASH/MASH)
This trial tests a new drug called HP515 for people with non-alcoholic fatty liver disease, including NASH or MASH. It aims to see if the drug can help reduce liver fat and improve liver health.
Beijing, Beijing MunicipalityAges 18–65 - NCT07314294RecruitingPhase 2
Study of EMB-01 for advanced left-sided colorectal cancer
This trial tests a new drug, EMB-01, in people with advanced left-sided colorectal cancer that has spread or cannot be removed. It may help if standard treatments have stopped working or caused side effects.
BeijingAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,408 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.